UPDATE: According to a statement from WHO Friday, Merck & Co.'s VSV-EBOV vaccine has proven "highly effective,” with 100 percent efficacy in clinical trials. The vaccine was developed by an Ames-Iowa based pharmaceutical called NewLink and commissioned by the Public Health Agency of Canada.
Tech 
The Race for the Ebola Vaccine
SPRINTING
With Ebola still raging in West Africa, the race to find a vaccine is heating up. Which drug company will be first to the finish line?
Trending Now
